Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy…
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced its Gyrolab® Generic Anti-Adeno Associated Virus (AAV) Kit. The new ready-to-use…
Read More...
Read More...